This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Find out which cash back cards come with no annual fees. Maximize your savings and enjoy great rewards!
27,891 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
A 69-year-old widow faces a six-figure tax bill after considering rolling her late husband’s traditional IRA into her...
Momentum can tilt a portfolio toward recent winners. This article explains how two Vanguard ETFs using momentum aim t...
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Three dividend aristocrats have boosted payouts for a combined 187 years, delivering steady passive income for invest...
When Palantir reveals new AI-focused capabilities, Nvidia stock often faces a unique set of pressures. This guide bre...
A founder sold a meaningful chunk of stock, but does that signal trouble or a routine liquidity move? This article br...
On a volatile trading day, fuelcell energy stock tumbling becomes a talking point for traders and long-term holders a...
Can investing in international developed markets through VEA actually be the smartest investment make right? This gui...
Alphabet is branching far beyond search, funding a sweeping AI infrastructure push. This article unpacks why wall str...
A single public remark can ripple through the arts ecosystem and even into personal finances. This article explains h...
A late-career couple spends about $48,000 yearly supporting an aging parent and adult child, delaying retirement and ...